All News
Filter News
Found 808,890 articles
-
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 06, 2023
9/6/2023
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced that the compensation committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 90,000 shares of its common stock to two employees outside Fusion's 2020 Stock Option and Incentive Plan.
-
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
9/6/2023
Motus GI Holdings, Inc., a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors.
-
IRADIMED CORPORATION to Participate at Upcoming September 2023 Investor Conferences
9/6/2023
IRADIMED CORPORATION announced that the Company will be participating in two upcoming investor conferences.
-
Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
9/6/2023
Aditxt, Inc. announced that it has closed its previously announced private placement for the purchase and sale of an aggregate of 1,000,000 shares of common stock at a purchase price of $10.00 per share and accompanying warrant, priced at-the-market under Nasdaq rules.
-
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
9/6/2023
Organogenesis Holdings Inc. announced that company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from September 11th-13th.
-
SpineThera Announces Breakthrough Market Research Results for SX600 in the Management of Sciatica Pain
9/6/2023
SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an independent market research study.
-
Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine
9/6/2023
Proteros biostructures GmbH announced a new collaboration with Orion Corporation.
-
atai Life Sciences to Participate in Upcoming September 2023 Investor Conferences
9/6/2023
atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming September Investor Conferences.
-
IBM Addresses Data Incident for Janssen CarePath Database
9/6/2023
IBM is notifying Janssen CarePath customers and users of an incident involving unauthorized access to personal information contained within a database used on the Janssen CarePath platform, a patient support platform that offers savings options and other patient support resources.
-
Asahi Kasei to Present Diversified Material Solutions for EV Batteries and Circular Economy at Fakuma 2023
9/6/2023
Japanese technology company Asahi Kasei will showcase diversified material solutions for safe and compact EV batteries, improved connectivity and lightweighting, as well as circular economy at Fakuma, the world's leading trade event for industrial plastics processing, from October 17th to 21st, 2023 in Friedrichshafen, Germany.
-
Most Non-English Speakers in the U.S. Are Turned Away Before Their First Cancer Visit According to New Research in JNCCN
9/6/2023
New research in the September 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network reveals an alarming lack of access for non-English speakers who called hospitals across the United States looking for information on cancer care services.
-
Cidara to Present at the 25th Annual H.C. Wainwright Global Investment Conference
9/6/2023
Cidara Therapeutics, Inc. announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will present at the 25th Annual H.C. Wainwright Global Investment Conference.
-
PharmAla Begins Trading on OTCQB
9/6/2023
PharmAla Biotech Holdings Inc. is pleased to announce that it has qualified for trading on the OTCQB Venture Market in the United States operated by the OTC Markets Group Inc. and the Company's common shares commenced trading on the OTCQB under the symbol "PMBHF”.
-
Align Technology Introduces New Software Innovations Designed to Accelerate Digital Practice Transformation
9/6/2023
Align Technology, Inc. introduced new software innovations to accelerate digital practice transformation.
-
CANbridge to Participate in Two Investor Conferences in September 2023
9/6/2023
CANbridge Pharmaceuticals Inc., a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced its participation in two upcoming investor conferences.
-
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - September 06, 2023
9/6/2023
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to four new employees.
-
Lisata Therapeutics Announces Outcome of Interim Futility Analysis for its Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma
9/6/2023
Lisata Therapeutics, Inc. announced a positive outcome of the prespecified interim futility analysis for the ASCEND trial, a Phase 2b study evaluating LSTA1, Lisata’s lead investigational product, in combination with standard-of-care gemcitabine/nab-paclitaxel in patients with first-line, metastatic pancreatic ductal adenocarcinoma.
-
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
9/6/2023
Stereotaxis announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis Robotic Magnetic Navigation System.
-
Isotopia Issues a call to action to the radionuclide Therapy industry.
9/6/2023
Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes.
-
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
9/6/2023
Nova Eye Medical Limited is pleased to announce that the Company’s proprietary canaloplasty technology platform will be featured in numerous presentations and posters during the official scientific program of the European Society of Cataract and Refractive Surgeons 41st Congress on September 8-12, 2023 in Vienna, Austria.